Inhibition of expression of beta-lactamase using esters of fatty acid alcohols
AssigneePublic Health Research Institute
InventorsSusan Brown-Skrobot, Richard P. Novick, Steven J. Projan
Life of this patent
Estimating the term…
Abstract
A class of chemical compounds comprising fatty acid ester derivatives used to inhibit beta-lactamase production by infectious bacteria. These inhibitors have been found to retard the resistance of certain strains of bacteria to beta-lactam antibiotics, such as penicillin, by interfering with the transcription of the beta-lactamase gene and precluding expression of beta-lactamase. In accordance therewith, these inhibitors permit effective treatment of infections of otherwise resistive bacteria with antibiotics.
Claims3
A composition for inhibiting beta-lactamase expression in bacteria, comprising a fatty acid selected from the group consisting of caprylic acid, capric acid, myristic acid, palmitic acid, stearic acid and oleic acid and a polyhydric aliphatic alcohol selected from the group consisting of 1,2-ethanediol, 1,3-propanediol, 1,4-butanediol and 1,2,4-butanetriol, in an amount effective to inhibit beta-lactamase expression by said bacteria, and a pharmaceutically acceptable carrier, wherein said carrier further comprises an antibiotic selected from the group consisting of amoxicillin, ampicillin, methicillin, penicillin and cephalosporin, and wherein the final effective concentration of said composition is 3-30 .mu.g/ml and the dose of said antibiotic is 500-4000 mg.
A composition for inhibiting beta-lactamase expression in bacteria, comprising:
- a. a first fatty acid selected from the group consisting of caprylic acid, capric acid, myristic acid, palmitic acid, stearic acid and oleic acid and a first polyhydric aliphatic alcohol selected from the group consisting of 1,2-ethanediol, 1,3-propanediol, 1,4-butanediol and 1,2,4-butanetriol;
- b. a second fatty acid selected from the group consisting of caprylic acid, capric acid, myristic acid, palmitic acid, stearic acid and oleic acid and a second polyhydric aliphatic alcohol selected from the group consisting of 1,2-ethanediol, 1,3-propanediol, 1,4-butanediol and 1,2,4-butanetriol, and
- c. a pharmaceutically acceptable carrier containing an antibiotic selected from the group consisting of amoxicillin, ampicillin, methicillin, penicillin and cephalosporin.
Dependencies are inferred from the claim text.